Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04023396
What this trial is testing

Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abivax S.A. 217
Testing effectiveness (Phase 2)Study completedNCT03677648
What this trial is testing

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Reistone Biopharma Company Limited 112
Testing effectiveness (Phase 2)Looking for participantsNCT06958536
What this trial is testing

Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease

Who this might be right for
Crohn's Disease
Sanofi 99
Testing effectiveness (Phase 2)Study completedNCT02589665
What this trial is testing

Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 249
Testing effectiveness (Phase 2)Study completedNCT00294112
What this trial is testing

Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease

Who this might be right for
Crohn's Disease
Mesoblast, Inc. 10
Not applicableActive Not RecruitingNCT05930275
What this trial is testing

Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.

Who this might be right for
Crohn's Disease
AbbVie 1,200
Post-approval studies (Phase 4)Ended earlyNCT02579733
What this trial is testing

Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Kyungpook National University Hospital 16
Large-scale testing (Phase 3)Not Yet RecruitingNCT07650942
What this trial is testing

Hemay005 for the Treatment of Chinese Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Ganzhou Hemay Pharmaceutical Co., Ltd 360
Not applicableStudy completedNCT02506179
What this trial is testing

Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 100
Large-scale testing (Phase 3)Study completedNCT02065557
What this trial is testing

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
AbbVie 101
Testing effectiveness (Phase 2)Looking for participantsNCT07697456
What this trial is testing

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Who this might be right for
Crohn's DiseaseUlcerative Colitis
AbbVie 2,000
Testing effectiveness (Phase 2)Study completedNCT01620255
What this trial is testing

PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Shire 357
Large-scale testing (Phase 3)Ended earlyNCT03961815
What this trial is testing

Open-label Extension Study of Brazikumab in Crohn's Disease

Who this might be right for
Crohn's DiseaseIBD
AstraZeneca 18
Large-scale testing (Phase 3)Study completedNCT04779307
What this trial is testing

Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)

Who this might be right for
Colitis, Ulcerative
Takeda 121
Testing effectiveness (Phase 2)Study completedNCT04004611
What this trial is testing

Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 26
Large-scale testing (Phase 3)Ended earlyNCT01536418
What this trial is testing

An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
GlaxoSmithKline 255
Post-approval studies (Phase 4)Study completedNCT02155335
What this trial is testing

Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027)

Who this might be right for
Ulcerative Colitis
Merck Sharp & Dohme LLC 100
Testing effectiveness (Phase 2)WithdrawnNCT05057273
What this trial is testing

Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease

Who this might be right for
Crohn's Disease
NImmune Biopharma
Testing effectiveness (Phase 2)Study completedNCT00234741
What this trial is testing

Study of STA-5326 Mesylate in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Synta Pharmaceuticals Corp. 12
Large-scale testing (Phase 3)Study completedNCT02914522
What this trial is testing

Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Gilead Sciences 1,351
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation